以D-果糖为原料利用新型异构酶转化生产D-阿洛糖

稀少糖是自然界中含量稀少、化学合成困难的一类低热量单糖。D-阿洛糖是一种重要的稀少己醛糖,其具有减少活性自由基、抑制癌细胞增殖等独特的生理学功能。因此,以微生物发酵生产D-阿洛酮糖-3-差向异构酶(DPE)和L-鼠李糖异构酶(L-RhI)转化生产D-阿洛糖,成为近几年来国际研究的热点之一。文中分别克隆了来源于解纤维梭菌Clostridium cellulolyticum H10的DPE基因以及来源于枯草芽胞杆菌Bacillussubtilis 168的L-RhI基因,并分别使其在宿主菌B.subtilis及大肠杆菌Escherichia coli BL21(DE3)中得到了表达。进一步利用镍亲和层析和阴离子交换色谱等手段对这两种酶进行了纯化,并对这两种纯化后酶的转化能力进行了分析测定。结果表明,以D-果糖为原料利用两种异构酶依次转化获得D-阿洛酮糖及D-阿洛糖,其两步转化效率分别为27.34%和34.64%。     

生物法合成稀有己酮糖的研究进展

稀有糖是一类在自然界中存在但含量很低、同时具有重要生理功能的一类单糖及其衍生物,在膳食、保健、医药等领域中发挥着重要的作用。此外稀有糖还可以作为多种天然产物和药物的合成前体。然而稀有糖的合成成本较高,大大制约了其广泛应用。当前利用微生物和酶转化法合成稀有糖成为一种强有利的工具。综述了生物法合成稀有己酮糖(包括D-塔格糖、D-山梨糖、D-阿洛酮糖、L-塔格糖、L-果糖、L-山梨糖和1-脱氧-L-果糖等)的研究进展,探讨了稀有己酮糖合成策略的研究趋势。     

D-阿洛酮糖的功能及其生物合成研究进展

随着肥胖、糖尿病等代谢性疾病的发病率在全球范围急剧上升,人们对食品营养和健康等问题日益关注。D-阿洛酮糖作为重要的天然稀有己酮糖,不仅保持良好的甜度,而且具有降血糖、降血脂、抗氧化等功效,逐渐成为食品、保健和医疗领域的研究热点。文中阐述了D-阿洛酮糖的主要生理功能,综述了D-阿洛酮糖的生物合成研究进展及其酮糖3-差向异构酶的晶体结构,为筛选D-阿洛酮糖的产生菌株及提高合成酶的热稳定性和转化率提供理论指导,以满足工业化生产的需求。     

新型低热量甜味剂——D-阿洛酮糖的研究进展

寻找适合糖尿病人服用的甜味剂具有重要的经济价值。D-阿洛酮糖是D-果糖的C3差向异构体,是一种稀有糖。作为一种新型低热量甜味剂,D-阿洛酮糖近年来日益引起人们的重视。本文对国际上近年来发表的关于D-阿洛酮糖的药理活性资料进行了系统的总结。D-阿洛酮糖几乎不提供热量,具有显著的降血糖、降血脂效果,对糖尿病动物的胰岛β细胞有明显的保护作用。此外,D-阿洛酮糖无毒副作用,是一种食用安全的糖。这些研究结果说明:D-阿洛酮糖在预防和治疗糖尿病方面具有极大的潜力,可以作为糖尿病人食用的新型甜味剂,具有良好的市场前景。     

链霉菌来源D-甘露糖异构酶的性质及其在制备D-甘露糖中的应用

【背景】D-甘露糖具有多种功能活性,在食品、医药、饲料等行业应用广泛。D-甘露糖异构酶可以催化D-果糖与D-甘露糖之间的相互转化,在D-甘露糖的酶法制备中具有应用潜力。【目的】克隆一个链霉菌(Streptomycessp.)来源的D-甘露糖异构酶基因(ssMIaseA)并在大肠杆菌中表达,研究其酶学性质,并用于制备D-甘露糖。【方法】从链霉菌(Streptomycessp.)中发掘一个D-甘露糖异构酶基因(ssMIaseA),构建重组表达质粒pET-28a-ssMIaseA并在大肠杆菌BL21(DE3)中表达,经Ni-NTA亲和层析纯化后测定酶学性质,利用高效液相色谱对SsMIaseA制备D-甘露糖进行研究。【结果】SsMIaseA与嗜热裂孢菌(Thermobifda fusca)来源的D-甘露糖异构酶ManI相似性最高,为60.2%。该酶比酶活为525 U/mg,分子量约为45 kD,最适pH和温度分别为7.5和45°C,在pH 6.5-10.0范围内和45°C以下保持稳定。该酶对甘露糖具有最高催化活性,其次是果糖、塔罗糖和塔格糖。利用SsMIaseA转化600 g/L D-果糖,反应8 h达到平衡,生成185 g/L D-甘露糖,转化率为31%。【结论】SsMIaseA作为新型D-甘露糖异构酶为D-甘露糖的酶法制备奠定了基础。     

基于双酶级联协调表达策略高效催化合成D-甘露醇北大核心CSCD

D-甘露醇(D-mannitol)作为合成抗肿瘤药和免疫刺激剂的重要前体被广泛应用于制药和医疗等行业,酶法合成D-甘露醇反应成本昂贵无法满足工业化生产。本研究首先筛选关键酶获得较优性能的甘露醇脱氢酶Lp MDH和用于辅因子NADH再生的葡萄糖脱氢酶Ba GDH,在大肠杆菌(Escherichia coli)BL21(DE3)中共表达,实现了基于双酶级联反应催化底物D-果糖合成D-甘露醇,D-甘露醇的初步摩尔转化率为59.7%。针对双酶级联催化反应中辅酶再生用酶与催化用酶表达量不协调的问题,通过增加Bagdh拷贝量来提高辅因子循环能力,获得了双酶催化速率平衡的重组大肠杆菌E.coli BL21/pETDuet-Lpmdh-Bagdh-Bagdh。进一步对重组菌的全细胞转化条件进行优化,确定了最适转化条件为反应温度30℃,初始pH值6.5,菌体量OD600=30,底物D-果糖100.0 g/L,辅底物葡萄糖与底物1︰1摩尔当量。于最优转化条件下5 L发酵罐转化24 h,D-甘露醇的最高产量为81.9g/L,摩尔转化率为81.9%。本研究提供了一种绿色、高效生物催化生产D-甘露醇的方法,为实现其规模化生产奠定了基础,同时也对其他相关稀有糖醇的研究具有指导意义。     

双酶偶联转化富马酸制备β-丙氨酸的工艺的建立与优化

酶转化法是生产β-丙氨酸的重要途径,但单一酶法转化存在底物价格较高的问题。通过构建双酶催化体系制备β-丙氨酸,即将来源于大肠杆菌的天冬氨酸酶(AspA)和来源于谷氨酸棒杆菌的L-天冬氨酸α-脱羧酶(PanD)偶联,以富马酸和氨为底物进行酶促反应合成β-丙氨酸。催化反应中AspA与PanD的最适加酶比例为1∶80,其中AspA的浓度为10μg/mL,转化温度为37℃,pH为7.0;浓度为100 mmol/L的富马酸可在8 h内被完全转化,转化率为100%,摩尔产率为90.9%,β-丙氨酸的产量为90 mmol/L,约为7 g/L;浓度为200 mmol/L的富马酸在反应8 h后,体系中β-丙氨酸的产量为126 mmol/L,约合9.8 g/L,继续延长反应时间,转化率并没有明显提高。根据该研究提出的双酶偶联转化工艺可将价格低廉的富马酸一步转化为具有高附加值的β-丙氨酸。     

d-阿洛酮糖3-差向异构酶重组枯草芽孢杆菌构建及固定化应用

d-阿洛酮糖3-差向异构酶 (d-allulose-3-epimerase) 是异构化d-果糖生成d-阿洛酮糖 (d-allulose) 的关键酶。为提高d-阿洛酮糖3-差向异构酶的热稳定性并获得可重复使用的d-阿洛酮糖3-差向异构酶重组枯草芽孢杆菌固定化细胞,N端融合双亲短肽,通过聚丙烯酰胺凝胶电泳 (SDS-PAGE) 分析,异源d-阿洛酮糖3-差向异构酶在枯草芽孢杆菌中正确折叠,蛋白大小为33 kDa。40 ℃孵育48 h,SAP1-DSDPEase残余酶活仍保持在58%。固定化细胞最优条件为海藻酸钠浓度2%、二氧化钛添加量1︰4 (二氧化钛︰海藻酸钠)、氯化钙溶液浓度2%、戊二醛0.02%作为交联剂。该条件下固定化细胞酶活回收率高达82%,固定化细胞与游离细胞相比,最适反应温度不变均为80 ℃,热稳定性提高,连续10次操作使用,酶活回收率仍保留58%,机械强度仍保持100%,转化率仍保持在28.8%,残余酶活保持在70.5%。在海藻酸钠溶液中加入二氧化钛可减少固定化细胞的细胞泄露,增大了机械强度。     

稀有糖的生物转化生产策略：Izumoring方法

稀有糖是在自然界中存在但含量极少的一类单糖及衍生物,其在膳食、保健、医药等领域中发挥着重要的功能。本文综述了一种稀有糖的生物转化生产策略----Izumoring方法,即利用D-塔格糖3-差向异构酶、醛糖异构酶和多元醇脱氢酶等进行所有单糖及糖醇之间的相互转化;利用该原则,分别构建了己糖类、戊糖类和丁糖类的Izumoring转化策略,并可获得所有稀有糖的酶反应和生物转化生产途径。同时,展望了稀有糖生物转化生产的研究趋势。     

马克斯克鲁维酵母菌菊粉酶的异源表达及低聚果糖制备工艺优化

【目的】低聚果糖是新型的食品和保健品原料,具有广阔的市场需求。以菊粉酶水解菊粉制备低聚果糖的酶法工艺是先进的绿色制造。本研究旨在获得高产的菊粉酶菌株及以菊粉为原料酶法制备低聚果糖的优化工艺。【方法】采用基因工程手段克隆马克斯克鲁维酵母菌(Kluyveromyces marxianus)的菊粉酶基因,实现其在毕赤酵母中的高效表达;测定菊粉酶在不同p H、温度、金属离子和底物浓度等条件下的酶活变化趋势,获得最佳的反应参数;通过高效液相色谱法检测水解产物,获得不同酶量水解产物各组分分布。【结果】菊粉酶工程菌株在10 L发酵罐中的产菊粉酶活达1 570 U/m L、蛋白质含量为2.75 g/L发酵液;菊粉酶最适反应参数为:在体积为1 L的反应体系中,p H 5.0、反应温度50°C、含0.2 mmol/L Mg2+以及菊粉浓度为8%。在该条件下,酶量为10 U时菊粉被完全水解。水解产物中单糖和二糖含量仅为9.25%,而低聚果糖(C3-C8)含量为90.75%,且C3-C5低聚果糖含量高达72.92%。【结论】克隆了K.marxianus菊粉酶基因并实现了高效表达,获得了水解菊粉制备低聚果糖的最佳工艺条件。为菊粉酶的大量生产及低聚果糖的酶法制备奠定了良好的基础。     

Respiration and soluble sugar metabolism in sugar pine embryos

Embroys excised from dormant seeds of sugar pine ( Pinus lambertiana Dougl.) incubated at 25°C (non-dormancy-breaking) or stratified at 5°C (dormancy-breaking) were analyzed to determine temperature effects on the relative activities of respiration and fermentative metabolism, the levels of soluble sugers and the activities of the hydrolytic enzymes, invertase and sucrose synthase, as related to the release of dormancy and germinatio. At 25°C, despite a sharp drop in embryo oxygen uptake after 48 h, a simultaneous decline in acetaldehyde and ethanol concentrations indicated that there was not a shift to fermentative metabolism. The concentrations of soluble sugars showed no treatment effects. Embryo invertase (EC 3.2.1.26) activity changed only slightly at either temperature, while stratification was accompanied by a 4-fold increase in sucrose synthase (EC 2.4.1.13) activity (cleavage direction). Upon transfer of stratified seeds to 25°C, embryo sucrose synthase activity rapidly increased almost 10-fold, with the increase beginning prior to germination, while mvertase activity increased 20-fold, concomitant with germination.     

One-step synthesis of non-anomeric sugar isothiocyanates from sugar azides

Tandem Staudinger-aza-Wittig reaction of primary azidodeoxy sugars with triphenylphosphine-carbon disulfide affords the corresponding primary deoxyisothiocyanato sugars in high yield. No products arising from O --> N acyl migration or formation of dimeric carbodiimides were observed. Interestingly, a polymer-supported triarylphosphine can advantageously replace triphenylphosphine, thus limiting the purification step to a simple filtration process. The reaction also allows the preparation of 5-deoxy-5-isothiocyanato sugars, a hitherto unknown class of compounds, from the corresponding azide precursors. Secondary sugar azides bearing the azido group at an endocyclic carbon atom afforded much lower isothiocyanation yields under these reaction conditions.     

Conversion of pyridylamino sugar chains to corresponding reducing sugar chains

Pyridylamino sugar chains were converted to the corresponding reducing sugar chains by first converting them to 1-amino-1-deoxy derivatives using the method previously reported [S. Hase, J. Biochem. 112, 266-268 (1992)] and then converting the products to the corresponding reducing sugar chains using the Sommlet reaction. The reaction conditions were optimized so as to obtain the maximal product yield using 1-amino-1-deoxylactose and 1-amino-1-deoxy-N-acetylglucosamine. When the established procedure was successively applied to pyridylamino high-mannose and complex-type sugar chains, the corresponding reducing sugar chains were obtained in yields of 30%.     

The human erythrocyte sugar transporter presents two sugar import sites

The human erythrocyte sugar transporter presents sugar import (e2) and sugar export (e1) sites simultaneously. This study asks whether the sugar transporter exposes only one or multiple import sites. We approached this question by analysis of cytochalasin B binding to the human erythrocyte sugar export site in the presence of sugars that bind to the sugar import site. Extracellular maltose does not enter human erythrocytes. High concentrations of maltose (1-100 mM) inhibit cytochalasin B binding to human red cells. Low concentrations (25-500 microM) increase the level of erythrocyte cytochalasin B binding. Maltose modulation of cytochalasin B binding is mediated by altered affinity of sugar export sites for cytochalasin B. Similar results are obtained with other cell-impermeant inhibitors of sugar uptake. Extracellular D-glucose (a transported sugar) stimulates cytochalasin B binding at low D-glucose concentrations (10-250 microM), but this effect is lost at higher concentrations. Intracellular D-glucose inhibits cytochalasin B binding. Low concentrations of extracellular maltose and other nontransported inhibitors stimulate 3-O-methylglucose uptake in erythrocytes. Higher sugar concentrations (1-100 mM) inhibit transport. These data support the hypothesis that the erythrocyte sugar transporter presents two sugar import sites and at least one sugar export site. This conclusion is consistent with the proposed oligomeric structure of the sugar transporter, a complex of four GluT1 proteins in which each subunit presents a translocation pathway.     

Reducing sugar accumulation from alkali pretreated sugar cane bagasse using Cellulomonas

Summary An active cellulolytic culture was obtained following growth of the Cellulomonas strain CS1-17 for 24 h at 32° C on 1 or 2% alkali pretreated sugar cane bagasse. Environmental conditions were then varied to favour reducing sugar accumulation from fresh alkali pretreated bagasse added to the 24 h culture medium at 75 g/l. After incubation for an additional 48 h at 37° C under anaerobic, aerobic and aerobic+0.2% sodium azide conditions, reducing sugar was accumulated at 22.8, 23.7 and 25.6 g/l respectively. Approximately 83% of this release occurred during the first 18 h of incubation and the reducing sugar released contained approximately 14% xylose, 35% glucose, and 26% cellobiose. Addition of exogenous cellobiase resulted in conversion of the cellobiose to glucose.